Acquisition Announced Sponsor buyer
Max Wygod acquisition of Forian
US$68m equity value
Announced 3 Apr 2026 · NASDAQ: FORA · US$2.17 cash per share
Advisers
Forian
Target
- Financial adviser
- Legal adviser
- Fairness opinion
Bravo Merger Sub
Acquirer
- Legal adviser
- A&O Shearman
(as Allen Overy Shearman Sterling US LLP) - Information agent for the Offer
- Broadridge Corporate Issuer Solutions
- Target
- Forian
- Acquirer
- Bravo Merger Sub (affiliate of Max Wygod-led consortium)
- Sponsor
- Max Wygod
- Target based in
- United States
- Buyer based in
- United States (unverified)
- Sector
- Healthcare Software
- Tags
- Healthcare Software, Data & Analytics
In the league tables
Similar deals
- Altaris acquisition of Life Sciences & Healthcare segment Jul 2026 · US$600m · Healthcare Software
- Qualtrics International acquisition of press ganey 2026 · US$6.8bn · Healthcare Software
- Neuberger stake in Datavant Sep 2026 · Healthcare Software
- ChartSpan acquisition of Validic Jun 2026 · Healthcare Software
- Medisolv acquisition of Lilac Software May 2026 · Healthcare Software
Sources
- 3 Apr 2026 Press release (EX-99.1, exhibit), Enters into Definitive Agreement to Become a Private Company sec.gov
- 16 Apr 2026 Tender offer statement (SC TO-T), Forian Inc. sec.gov
- 16 Apr 2026 Target response to tender offer (SC 14D9), Forian Inc. sec.gov